Quantum Genomics SA (ALQGC):企業の財務・戦略的SWOT分析

◆英語タイトル:Quantum Genomics SA (ALQGC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH136539FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Quantum Genomics SA (Quantum Genomics) is a bio pharmaceutical company which develops novel medicines in the field of cardiovascular diseases. The company develops drugs to treat high blood pressure and heart failure. Its research programs are based on the Brain Aminopeptidase A Inhibition (BAPAI), a real triple action innovative therapeutic platform. Quantum Genomics BAPAI products pipeline include QGC001 for the treatment of high blood pressure with monotherapy drug; and QGC011 for the treatment of hypertension through combination therapy in pre-clinical phase. Quantum Genomics offers QGC006 for the optimization of the treatment of hypertension with a monotherapy drug; and QGC101 for the prevention and treatment of heart failure. The company partners with biotech research entities, academic teams and pharmaceutical and bio-science companies to develop new drugs. QGS is headquartered in Paris, Ile-de-France, France.

Quantum Genomics SA Key Recent Developments

Mar 25,2021: Quantum Genomics Reports Full Year 2020 Operating and Financial Results
Feb 09,2021: Orient EuroPharma acquires Equity Stake in Quantum Genomics
Apr 07,2020: Quantum Genomics provides update on the impact of the COVID-19 health crisis on clinical research activities
Mar 26,2020: Quantum Genomics secured new financing, published its financial statements for fiscal year 2019 and provides 2019 highlights

This comprehensive SWOT profile of Quantum Genomics SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Quantum Genomics SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Quantum Genomics SA – Key Information
Quantum Genomics SA – Overview
Quantum Genomics SA – Key Employees
Quantum Genomics SA – Key Employee Biographies
Quantum Genomics SA – Key Operational Heads
Quantum Genomics SA – Major Products and Services
Quantum Genomics SA – History
Quantum Genomics SA – Company Statement
Quantum Genomics SA – Locations And Subsidiaries
Quantum Genomics SA
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Quantum Genomics SA – Business Description
Quantum Genomics SA – Corporate Strategy
Quantum Genomics SA – SWOT Analysis
SWOT Analysis – Overview
Quantum Genomics SA – Strengths
Quantum Genomics SA – Weaknesses
Quantum Genomics SA – Opportunities
Quantum Genomics SA – Threats
Quantum Genomics SA – Key Competitors

Section 3 – Company Financial Performance Charts

Quantum Genomics SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Quantum Genomics SA, Key Information
Quantum Genomics SA, Key Ratios
Quantum Genomics SA, Share Data
Quantum Genomics SA, Major Products and Services
Quantum Genomics SA, History
Quantum Genomics SA, Key Employees
Quantum Genomics SA, Key Employee Biographies
Quantum Genomics SA, Key Operational Heads
Quantum Genomics SA, Other Locations
Quantum Genomics SA, Subsidiaries
Quantum Genomics SA, Key Competitors
Quantum Genomics SA, SWOT Analysis
Quantum Genomics SA, Ratios based on current share price
Quantum Genomics SA, Annual Ratios
Quantum Genomics SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Quantum Genomics SA (ALQGC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Micro Labs Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Micro Labs Ltd (Micro Labs) is a healthcare service organization which conducts research and development of bio equivalent generics. The organization’s business segments include formulations and active pharmaceutical ingredients. Its products include acetamide, allercet, amiodar, amlong, aml …
  • Robins & Morton LLC:企業の戦略・SWOT・財務情報
    Robins & Morton LLC - Strategy, SWOT and Corporate Finance Report Summary Robins & Morton LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • JXTG Holdings, Inc.:企業の戦略・SWOT・財務分析
    JXTG Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary JXTG Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Nila Infrastructures Ltd
    Nila Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report Summary Nila Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Re-Vana Therapeutics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Re-Vana Therapeutics Ltd (Re-Vana) is an ocular pharmaceutical and drug delivery company that develops and commercialization of biodegradable long- acting drug delivery platforms to treat ophthalmic conditions. The company provides drug delivery products such as OcuLief, an injectable platfo …
  • Epic Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Epic Sciences Inc (Epic Sciences) focuses to develop novel diagnostics for personalized treatment of cancer. The company develops AR-V7 test to identify and molecularly characterize circulating tumor cells in a blood sample. It also offers biopharma solutions such as resistance to AR signali …
  • Range Resources Corp (RRC)-石油・ガス分野:企業M&A・提携分析
    Summary Range Resources Corp (Range) is independent oil, natural gas and natural gas liquids (NGL) company that explores, develops, and acquires natural gas and oil properties in the US. It has oil and gas properties in the Appalachian basin and Northern Louisiana of the US. Range’s natural gas and …
  • Alexander & Baldwin Inc (ALEX):企業の財務・戦略的SWOT分析
    Alexander & Baldwin Inc (ALEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • ResCare Inc:企業の戦略的SWOT分析
    ResCare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Neviot Nature of Galilee Ltd.:企業の戦略・SWOT・財務分析
    Neviot Nature of Galilee Ltd. - Strategy, SWOT and Corporate Finance Report Summary Neviot Nature of Galilee Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Advanced Materials Enterprises Co Ltd:企業の製品パイプライン分析2018
    Summary Advanced Materials Enterprises Co Ltd (AME) is a laboratory equipment supplier. The company manufactures group of high precision mechanical components. It offers laboratory and professional equipment, consumer and lifestyle products, industrial heating system, and healthcare products. AME’s …
  • Sunrun Inc (RUN):企業の財務・戦略的SWOT分析
    Sunrun Inc (RUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Glacier Media Inc. (GVC):企業の財務・戦略的SWOT分析
    Glacier Media Inc. (GVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Martin Marietta Materials, Inc.:戦略・SWOT・企業財務分析
    Martin Marietta Materials, Inc. - Strategy, SWOT and Corporate Finance Report Summary Martin Marietta Materials, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Oman Oil Co SAOC:石油・ガス:M&Aディール及び事業提携情報
    Summary Oman Oil Company SAOC (Oman Oil Company) is an oil and gas service provider that offers investment facilities for the growth and development of energy sector. The association invests and develops the areas of production, exploration, and related services, energy infrastructure and shipping, …
  • Grieg Seafood ASA:企業の戦略・SWOT・財務情報
    Grieg Seafood ASA - Strategy, SWOT and Corporate Finance Report Summary Grieg Seafood ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Davide Campari-Milano SpA:企業の戦略・SWOT・財務情報
    Davide Campari-Milano SpA - Strategy, SWOT and Corporate Finance Report Summary Davide Campari-Milano SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Selective Insurance Group, Inc. (SIGI):企業の財務・戦略的SWOT分析
    Selective Insurance Group, Inc. (SIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • HCA Healthcare, Inc.:企業の戦略・SWOT・財務分析
    HCA Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report Summary HCA Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • GOBARTO S.A.:戦略・SWOT・企業財務分析
    GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report Summary GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆